{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:19:40Z","timestamp":1791422380552,"version":"4.3.3"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.bbmt.2014.12.034","type":"journal-article","created":{"date-parts":[[2015,1,22]],"date-time":"2015-01-22T22:33:08Z","timestamp":1421965988000},"page":"S19-S24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"S","title":["Reprint of: Recent Advances in Cytomegalovirus: An Update on Pharmacologic and Cellular Therapies"],"prefix":"10.1016","volume":"21","author":[{"given":"Michael","family":"Boeckh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl S.","family":"Peggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2014.12.034_bib1","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.bbmt.2010.07.026","article-title":"An international comparison of current strategies to prevent herpesvirus and fungal infections in hematopoietic cell transplant recipients","volume":"17","author":"Pollack","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.12.034_bib2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1182\/asheducation-2011.1.305","article-title":"Complications, diagnosis, management, and prevention of CMV infections: current and future","volume":"2011","author":"Boeckh","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.bbmt.2014.12.034_bib3","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1517\/14712598.2012.693471","article-title":"Therapeutic strategies for the prevention and treatment of cytomegalovirus infection","volume":"12","author":"Sellar","year":"2012","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.bbmt.2014.12.034_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/bjh.12363","article-title":"Management of cytomegalovirus infection in haemopoietic stem cell transplantation","volume":"162","author":"Emery","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2014.12.034_bib5","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2141.2011.08988.x","article-title":"Management of multidrug-resistant viruses in the immunocompromised host","volume":"156","author":"Sellar","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2014.12.034_bib6","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/clpt.2010.178","article-title":"Update on new antivirals under development for the treatment of double-stranded DNA virus infections","volume":"88","author":"Dropulic","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bbmt.2014.12.034_bib7","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S1473-3099(11)70024-X","article-title":"Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial","volume":"11","author":"Marty","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bbmt.2014.12.034_bib8","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.coviro.2011.10.011","article-title":"Maribavir and human cytomegalovirus-what happened in the clinical trials and why might the drug have failed?","volume":"1","author":"Marty","year":"2011","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.bbmt.2014.12.034_bib9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jcv.2006.07.010","article-title":"Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or foscarnet","volume":"37","author":"Drew","year":"2006","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.bbmt.2014.12.034_bib10","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1128\/AAC.01596-09","article-title":"In\u00a0vitro and in\u00a0vivo activities of the novel anticytomegalovirus compound AIC246","volume":"54","author":"Lischka","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bbmt.2014.12.034_bib11","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.coviro.2011.10.015","article-title":"Progress in the development of new therapies for herpesvirus infections","volume":"1","author":"Price","year":"2011","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.bbmt.2014.12.034_bib12","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1600-6143.2011.03530.x","article-title":"First report of successful treatment of multidrug-resistant cytomegalovirus disease with the novel anti-CMV compound AIC246","volume":"11","author":"Kaul","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bbmt.2014.12.034_bib13","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1309533","article-title":"Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation","volume":"370","author":"Chemaly","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2014.12.034_bib14","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa1303688","article-title":"CMX001 to prevent cytomegalovirus\u00a0disease in hematopoietic-cell transplantation","volume":"369","author":"Marty","year":"2013","journal-title":"N\u00a0Engl J\u00a0Med"},{"key":"10.1016\/j.bbmt.2014.12.034_bib15","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2165\/10898540-000000000-00000","article-title":"New developments in the management of\u00a0cytomegalovirus infection after solid organ transplantation","volume":"70","author":"Eid","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.bbmt.2014.12.034_bib16","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/TP.0b013e3181e94106","article-title":"Utility of leflunomide in the treatment of complex cytomegalovirus syndromes","volume":"90","author":"Avery","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2014.12.034_bib17","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1038\/bmt.2012.46","article-title":"Evidence for clinical activity of artesunate in multidrug-resistant herpes simplex infection following HSCT","volume":"47","author":"Sellar","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.12.034_bib18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.antiviral.2011.03.184","article-title":"Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantation","volume":"90","author":"Wolf","year":"2011","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bbmt.2014.12.034_bib19","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1086\/587106","article-title":"Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation","volume":"46","author":"Shapira","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2014.12.034_bib20","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1182\/blood.V78.5.1373.1373","article-title":"Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease","volume":"78","author":"Reusser","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.12.034_bib21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3109\/14653249.2012.662769","article-title":"The role of virus-specific adoptive T-cell therapy in hematopoietic transplantation","volume":"14","author":"Sellar","year":"2012","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbmt.2014.12.034_bib22","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1126\/science.1352912","article-title":"Restoration of viral immunity\u00a0in immunodeficient humans by the adoptive transfer of T cell clones","volume":"257","author":"Riddell","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2014.12.034_bib23","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/nm1475","article-title":"Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals","volume":"12","author":"Leen","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.bbmt.2014.12.034_bib24","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1182\/blood.V99.11.3916","article-title":"Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy","volume":"99","author":"Einsele","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.12.034_bib25","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(03)14634-X","article-title":"Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines","volume":"362","author":"Peggs","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2014.12.034_bib26","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1086\/648422","article-title":"Cytomegalovirus-specific T cell immunotherapy promotes restoration of durable functional antiviral immunity following allogeneic stem cell transplantation","volume":"49","author":"Peggs","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2014.12.034_bib27","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1182\/blood-2012-08-448977","article-title":"Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation","volume":"121","author":"Blyth","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.12.034_bib28","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1182\/blood-2010-01-262089","article-title":"Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation","volume":"116","author":"Feuchtinger","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.12.034_bib29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/cid\/ciq042","article-title":"Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation","volume":"52","author":"Peggs","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2014.12.034_bib30","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1537-2995.2010.02940.x","article-title":"Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation","volume":"51","author":"Schmitt","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2014.12.034_bib31","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/cid\/cis625","article-title":"Rapid salvage treatment with virus-specific T cells for therapy-resistant disease","volume":"55","author":"Uhlin","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2014.12.034_bib32","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1182\/blood-2010-06-289991","article-title":"Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects","volume":"116","author":"Melenhorst","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.12.034_bib33","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/sj.bmt.1704959","article-title":"The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation","volume":"35","author":"Thomson","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.12.034_bib34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.7326\/0003-4819-118-3-199302010-00003","article-title":"Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant","volume":"118","author":"Goodrich","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2014.12.034_bib35","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1182\/blood-2013-02-486324","article-title":"Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation","volume":"121","author":"Leen","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.12.034_bib36","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1182\/blood-2009-03-213256","article-title":"Functionally active virus-specific T\u00a0cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes","volume":"114","author":"Hanley","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.12.034_bib37","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/bmt.2013.114","article-title":"Depletion of naive T cells using clinical grade magnetic CD45RA beads: a new approach for GVHD prophylaxis","volume":"49","author":"Teschner","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.12.034_bib38","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1084\/jem.134.6.1513","article-title":"Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F 1 hybrid mice","volume":"134","author":"Cudkowicz","year":"1971","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.bbmt.2014.12.034_bib39","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/eji.1830050208","article-title":"\u201cNatural\u201d killer cells in the mouse. I.\u00a0Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype","volume":"5","author":"Kiessling","year":"1975","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.bbmt.2014.12.034_bib40","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0065-2776(08)60034-6","article-title":"Biology and genetics of hybrid resistance","volume":"41","author":"Bennett","year":"1987","journal-title":"Adv Immunol"},{"key":"10.1016\/j.bbmt.2014.12.034_bib41","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1126\/science.8235625","article-title":"Immune responses in interleukin-2-deficient mice","volume":"262","author":"Kundig","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2014.12.034_bib42","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1084\/jem.191.5.771","article-title":"Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice","volume":"191","author":"Kennedy","year":"2000","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.bbmt.2014.12.034_bib43","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1084\/jem.20100570","article-title":"Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment","volume":"207","author":"Joncker","year":"2010","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.bbmt.2014.12.034_bib44","doi-asserted-by":"crossref","first-page":"5460","DOI":"10.1073\/pnas.0509249103","article-title":"Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T\u00a0cells","volume":"103","author":"Barao","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bbmt.2014.12.034_bib45","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1084\/jem.20051511","article-title":"CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-{beta}-dependent manner","volume":"202","author":"Ghiringhelli","year":"2005","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.bbmt.2014.12.034_bib46","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood.V97.10.3146","article-title":"Human natural killer cells: a\u00a0unique innate immunoregulatory role for the CD56 (bright) subset","volume":"97","author":"Cooper","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2014.12.034_bib47","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.bbmt.2003.09.002","article-title":"The immunobiology of natural killer cells and bone marrow allograft rejection","volume":"9","author":"Barao","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2014.12.034_bib48","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1084\/jem.188.12.2375","article-title":"Natural killer (NK cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells","volume":"188","author":"Zamai","year":"1998","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.bbmt.2014.12.034_bib49","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.semcancer.2006.07.003","article-title":"Positive and negative regulation of natural killer cells: therapeutic implications","volume":"16","author":"Hallett","year":"2006","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.bbmt.2014.12.034_bib50","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nature10624","article-title":"Natural killer cells act as rheostats modulating antiviral T cells","volume":"481","author":"Waggoner","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bbmt.2014.12.034_bib51","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.4049\/jimmunol.1400034","article-title":"Increased antitumor effects using IL-2 with anti-TGF-beta reveals competition between mouse NK and CD8 T cells","volume":"193","author":"Alvarez","year":"2014","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.bbmt.2014.12.034_bib52","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1084\/jem.20091193","article-title":"Innate immunity defines the capacity of antiviral T cells to limit persistent infection","volume":"207","author":"Andrews","year":"2010","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.bbmt.2014.12.034_bib53","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.mib.2010.05.011","article-title":"Modulation of natural killer cell activity by viruses","volume":"13","author":"Lisnic","year":"2010","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.bbmt.2014.12.034_bib54","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/ni714","article-title":"Specific and nonspecific NK cell activation during virus infection","volume":"2","author":"Dokun","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bbmt.2014.12.034_bib55","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature07665","article-title":"Adaptive immune features of natural killer cells","volume":"457","author":"Sun","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bbmt.2014.12.034_bib56","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature03847","article-title":"Licensing of natural killer cells by host major histocompatibility complex class I molecules","volume":"436","author":"Kim","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbmt.2014.12.034_bib57","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1172\/JCI1268","article-title":"Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation","volume":"101","author":"Asai","year":"1998","journal-title":"J\u00a0Clin Invest"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879114014785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879114014785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:53:11Z","timestamp":1761058391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879114014785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1083879114014785"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2014.12.034","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reprint of: Recent Advances in Cytomegalovirus: An Update on Pharmacologic and Cellular Therapies","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2014.12.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2014.11.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}